Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Toxic epidermic necrolysis].

Manuel Díaz de Leén-Ponce1, Armando Alberto Moreno-Santillán, Jorge Iván González-Díaz

  • 1Naranjo 94-303, Col. Santa María La Ribera, 06400 México, D.F., México. manueldeleonponce@hotmail.com

Cirugia Y Cirujanos
|January 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioelectrical impedance vector (BIVA) reference values for healthy term newborns 1-2 days old.

Clinical nutrition ESPEN·2025
Same author

Acute Fatty Liver of Pregnancy: Incidence and Clinical Evolution in Toluca, Mexico.

Puerto Rico health sciences journal·2024
Same author

Pregnancy-associated atypical hemolytic uremic syndrome. Case report.

The journal of obstetrics and gynaecology research·2024
Same author

Maternal Consumption of Non-Nutritive Sweeteners during Pregnancy Is Associated with Alterations in the Colostrum Microbiota.

Nutrients·2023
Same author

Incidental Diagnosis of Metastatic Breast Cancer in a Man With 99m Tc-PSMA SPECT/CT.

Clinical nuclear medicine·2023
Same author

Diagnosis of Traumatic Bronchobiliary Fistula With Late 99m Tc-Mebrofenin SPECT/CT.

Clinical nuclear medicine·2022
Same journal

Oral cavity cancer: retrospective analysis of a tertiary level hospital.

Cirugia y cirujanos·2026
Same journal

Volumetric computed tomography Hounsfield unit analysis: a superior method for opportunistic osteoporosis screening and assessment.

Cirugia y cirujanos·2026
Same journal

Pre-operative differentiation of atypical parathyroid tumors and parathyroid adenomas: Is it possible?

Cirugia y cirujanos·2026
Same journal

Challenges and outcomes of breast reconstruction in advanced-stage breast cancer: a comprehensive review.

Cirugia y cirujanos·2026
Same journal

Impact of anterior cruciate ligament and medial collateral ligament injuries on medial unicompartmental knee arthroplasty outcomes.

Cirugia y cirujanos·2026
Same journal

Laparoscopic retroperitoneal lymph node dissection in testicular cancer: feasibility and safety at a tertiary center.

Cirugia y cirujanos·2026
See all related articles

A novel treatment for toxic epidermal necrolysis (TEN) involving anticoagulants and antiplatelet drugs achieved 0% mortality in 12 patients. This approach effectively managed severe dermatological disease, improving patient outcomes.

Area of Science:

  • Dermatology
  • Internal Medicine
  • Pharmacology

Context:

  • Toxic epidermal necrolysis (TEN) is a severe dermatological condition with high mortality rates.
  • Conventional treatments for TEN have mortality rates exceeding 50%.

Purpose:

  • To evaluate a nonconventional treatment for toxic epidermal necrolysis (TEN).
  • To demonstrate the efficacy of early anticoagulation and antiplatelet therapy in managing TEN.

Summary:

  • A prospective study included 12 patients diagnosed with TEN via clinical presentation, drug history, and skin biopsy.
  • Patients received a combination treatment including heparin, dipyridamole, and supportive care, with one requiring peritoneal dialysis for acute renal failure.
  • All 12 patients recovered within 20-25 days, achieving a 0% mortality rate.

Related Experiment Videos

Impact:

  • This nonconventional treatment strategy resulted in 0% mortality for TEN patients.
  • Early intervention with anticoagulants and antiplatelet agents may prevent inflammatory mediators and multiple organ dysfunction in TEN.
  • Demonstrates a potentially life-saving alternative for managing severe toxic epidermal necrolysis.